Schroder Investment Management Group
JBIO

Schroder Investment Management Group’s Jade Biosciences JBIO Stock Holding History

Schroder Investment Management Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.11M Buy
140,886
+101,607
+259% +$2.12M ﹤0.01% 852
2026
Q1 		$521K Hold
39,279
– – ﹤0.01% 1090
2025
Q4 		$611K Buy
+39,279
New +$461K ﹤0.01% 1039

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Schroder Investment Management Group's JBIO Position: Q2 2026 in Review

Schroder Investment Management Group increased its Jade Biosciences (JBIO) stake by 259% in Q2 2026, buying an estimated $2.12M and bringing the position to 140,886 shares worth $3.11M. The position accounts for ﹤0.01% of the portfolio, ranked #852.

Schroder Investment Management Group first reported a position in JBIO in Q4 2025 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Schroder Investment Management Group held 140,886 shares of Jade Biosciences worth $3.11M as of Q2 2026.
  • Schroder Investment Management Group bought 101,607 Jade Biosciences shares in Q2 2026, an estimated $2.12M.
  • Jade Biosciences made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #852 holding.
  • Schroder Investment Management Group first reported a position in Jade Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.